Jim Cramer Notes Kimberly-Clark’s Stock Got “Clobbered” After Kenvue Acquisition Announcement

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the stocks Jim Cramer recently commented on. Cramer highlighted the company’s acquisition plans, as he commented:

“Now, I want you to contrast that with Kimberly-Clark, a great company, saw its stock get clobbered today after the company announced it was buying Kenvue. That’s the maker of Tylenol, Band-Aids, Neutrogena, among other brands… At one time, like so many other household names, Kimberly-Clark went from being a largely domestic company to a worldwide colossus… Kimberly-Clark’s growth rate got better and better and better, and the stock was a juggernaut.

Photo by AlphaTradeZone

Kimberly-Clark Corporation (NASDAQ:KMB) sells personal care and household products, including diapers, wipes, feminine and adult care products, tissues, paper towels, and soaps.

While we acknowledge the potential of KMB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

View Comments